Resins for Solid Phase Peptide Synthesis Market Share Driven by 100-200 Mesh Type and Expanding Demand from Pharmaceutical Companies | Valuates Reports

Resins for Solid Phase Peptide Synthesis Market Size
The global market for Resins for Solid Phase Peptide Synthesis was valued at US$ 71.7 million in the year 2023 and is projected to reach a revised size of US$ 424 million by 2030, growing at a CAGR of 27.1% during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-29V18522/Global_Resins_for_Solid_Phase_Peptide_Synthesis_Market_Research_Report_2024

The Resins for Solid Phase Peptide Synthesis (SPPS) market is witnessing steady growth as the pharmaceutical and research sectors increasingly adopt peptide-based solutions for drug development, diagnostics, and therapeutic research. These resins are critical for anchoring amino acids during peptide chain assembly, directly influencing synthesis quality-driving market size expansion and shaping market trends focused on precision synthesis, scalability, and bio-compatibility.

By type, the 100-200 mesh resins hold the largest market share, widely favored for their balanced properties that ensure optimal reagent penetration, effective mixing, and efficient filtration. This mesh size is highly compatible with automated peptide synthesizers and supports consistent performance in both research-scale and commercial production. The 200-400 mesh segment, although smaller, is gaining relevance in specialized applications that require higher surface area and loading capacity, particularly in high-throughput environments or when synthesizing complex sequences.

In terms of application, pharmaceutical companies dominate the market share, using SPPS resins extensively to develop novel peptide therapeutics, including hormone analogs, cancer treatments, and vaccines. With the rise of precision medicine and biologics, the demand for reliable, high-performance resins continues to increase. Colleges and universities form another significant segment, relying on these resins for academic research, drug discovery, and molecular biology instruction. The "Others" category includes biotech startups, contract research organizations, and industrial laboratories involved in peptide design, modification, or large-scale synthesis.

Looking ahead, the market forecast indicates sustained growth supported by rising investments in peptide-based drug pipelines, increasing demand for custom synthesis, and continuous improvements in resin chemistry. The Resins for Solid Phase Peptide Synthesis market is well-positioned for expansion as stakeholders across the pharmaceutical and research sectors seek dependable, high-yield synthesis materials to meet evolving therapeutic and technological demands.

by Type

• 100-200 Mesh
• 200-400 Mesh

by Application
• Pharmaceutical Companies
• Colleges and Universities
• Others

By Company

Sunresin, Merck, Agilent, Tianjin Nankai Hecheng Science & Technology, Activotec, RawPEG

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-29V18522/global-resins-for-solid-phase-peptide-synthesis

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.